FDA issued a Warning Letter to Magellan Diagnostics, Inc. on 10/23/2017 as a result of this inspection.
483 Magellan Diagnostics Jun 2017

483 Magellan Diagnostics Jun 2017

Suzanne Healy FDA, Ian Pilcher FDA, James Whitney FDA$119.00 - Available Now

FDA investigators audited the Magellan Diagnostics - North Billerica, MA, United States facility and issued 9 inspectional observations (via FDA 483) on 29 Jun 2017.

Product details

  • Category: Medical Devices & Rad Health
  • Number of Observations: 9
  • Inspection end: 29 Jun 2017
  • Location: North Billerica, United States
  • FEI: 1218996
Add To Cart